Source comparison
MOTS-c vs Other Mitochondrial Peptides: Mechanism Comparison
MOTS-c AMPK activation, mitochondrial biogenesis via PGC-1α upregulation 2–4 weeks for AMPK signaling, 8–12 weeks for full mitochondrial adaptation Moderate. Improves HOMA-IR by 15–20% in research models Best for metabolic flexibility and endurance adaptation.
This comparison does not assign a generated winner or score.
- MOTS-c
- AMPK activation, mitochondrial biogenesis via PGC-1α upregulation
- 2–4 weeks for AMPK signaling, 8–12 weeks for full mitochondrial adaptation
- Moderate. Improves HOMA-IR by 15–20% in research models
- Best for metabolic flexibility and endurance adaptation. Requires training stimulus to maximize
- Humanin
- Neuroprotective, apoptosis inhibition, STAT3 activation
- 4–6 weeks for cellular stress resistance markers
- Minimal direct effect. Indirect via reduced oxidative stress
- Primary use is neuroprotection and longevity pathways, not acute metabolic performance
- SS-31 (Elamipretide)
- Cardiolipin stabilization, electron transport chain efficiency
- 1–2 weeks for ATP production improvements
- Minimal. Mechanistically distinct from insulin signaling
- Fastest-acting mitochondrial peptide for acute energy production, lacks biogenesis signaling
- NAD+ precursors (NMN/NR)
- Sirtuin activation, NAD+ repletion for mitochondrial enzyme function
- 2–3 weeks for NAD+ levels, 6–8 weeks for mitochondrial markers
- Moderate. Improves insulin sensitivity via SIRT1 activation
- Complementary to MOTS-c but works via different pathway. Can be stacked